nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—CYP4A11—Rifampicin—leprosy	0.34	0.397	CbGbCtD
Lansoprazole—CYP2C18—Dapsone—leprosy	0.123	0.144	CbGbCtD
Lansoprazole—CYP1A1—Thalidomide—leprosy	0.064	0.0747	CbGbCtD
Lansoprazole—CYP2C8—Rifampicin—leprosy	0.0358	0.0418	CbGbCtD
Lansoprazole—CYP2C19—Thalidomide—leprosy	0.031	0.0362	CbGbCtD
Lansoprazole—CYP2C19—Rifampicin—leprosy	0.03	0.035	CbGbCtD
Lansoprazole—CYP2C8—Dapsone—leprosy	0.0295	0.0345	CbGbCtD
Lansoprazole—CYP1A2—Thalidomide—leprosy	0.0286	0.0334	CbGbCtD
Lansoprazole—CYP1A2—Rifampicin—leprosy	0.0277	0.0323	CbGbCtD
Lansoprazole—CYP2C9—Thalidomide—leprosy	0.0257	0.0301	CbGbCtD
Lansoprazole—CYP2C9—Rifampicin—leprosy	0.0249	0.0291	CbGbCtD
Lansoprazole—CYP2C19—Dapsone—leprosy	0.0248	0.0289	CbGbCtD
Lansoprazole—ABCB1—Rifampicin—leprosy	0.0242	0.0283	CbGbCtD
Lansoprazole—CYP2C9—Dapsone—leprosy	0.0206	0.024	CbGbCtD
Lansoprazole—CYP3A4—Rifampicin—leprosy	0.0145	0.0169	CbGbCtD
Lansoprazole—CYP3A4—Dapsone—leprosy	0.012	0.014	CbGbCtD
Lansoprazole—Avitaminosis—Thalidomide—leprosy	0.00752	0.0523	CcSEcCtD
Lansoprazole—Joint sprain—Dapsone—leprosy	0.0069	0.048	CcSEcCtD
Lansoprazole—Hypovitaminosis—Thalidomide—leprosy	0.00676	0.047	CcSEcCtD
Lansoprazole—Ligament sprain—Dapsone—leprosy	0.00548	0.0381	CcSEcCtD
Lansoprazole—Albuminuria—Dapsone—leprosy	0.00186	0.0129	CcSEcCtD
Lansoprazole—Dementia—Thalidomide—leprosy	0.00173	0.012	CcSEcCtD
Lansoprazole—Paraesthesia oral—Thalidomide—leprosy	0.00151	0.0105	CcSEcCtD
Lansoprazole—Neck stiffness—Thalidomide—leprosy	0.00149	0.0104	CcSEcCtD
Lansoprazole—Transient ischaemic attack—Thalidomide—leprosy	0.0014	0.00977	CcSEcCtD
Lansoprazole—Lactic dehydrogenase activity increased—Thalidomide—leprosy	0.00139	0.00964	CcSEcCtD
Lansoprazole—Nuchal rigidity—Thalidomide—leprosy	0.00137	0.00951	CcSEcCtD
Lansoprazole—Hostility—Thalidomide—leprosy	0.00128	0.00891	CcSEcCtD
Lansoprazole—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.00122	0.00849	CcSEcCtD
Lansoprazole—Platelet count decreased—Thalidomide—leprosy	0.00119	0.00829	CcSEcCtD
Lansoprazole—Enlargement abdomen—Thalidomide—leprosy	0.00118	0.0082	CcSEcCtD
Lansoprazole—Deep vein thrombosis—Thalidomide—leprosy	0.00117	0.00811	CcSEcCtD
Lansoprazole—Myasthenia—Thalidomide—leprosy	0.00113	0.00785	CcSEcCtD
Lansoprazole—Hypomagnesaemia—Thalidomide—leprosy	0.00112	0.00776	CcSEcCtD
Lansoprazole—Oral candidiasis—Thalidomide—leprosy	0.00112	0.00776	CcSEcCtD
Lansoprazole—Hypothyroidism—Thalidomide—leprosy	0.0011	0.00768	CcSEcCtD
Lansoprazole—Tooth disorder—Thalidomide—leprosy	0.00109	0.0076	CcSEcCtD
Lansoprazole—Nail disorder—Thalidomide—leprosy	0.00109	0.0076	CcSEcCtD
Lansoprazole—Menstrual disorder—Thalidomide—leprosy	0.00104	0.00724	CcSEcCtD
Lansoprazole—Hypercalcaemia—Thalidomide—leprosy	0.00102	0.0071	CcSEcCtD
Lansoprazole—Hepatomegaly—Thalidomide—leprosy	0.001	0.00697	CcSEcCtD
Lansoprazole—Interstitial lung disease—Thalidomide—leprosy	0.001	0.00697	CcSEcCtD
Lansoprazole—Hyperlipidaemia—Thalidomide—leprosy	0.000984	0.00684	CcSEcCtD
Lansoprazole—Albuminuria—Thalidomide—leprosy	0.00095	0.00661	CcSEcCtD
Lansoprazole—Amblyopia—Thalidomide—leprosy	0.000918	0.00639	CcSEcCtD
Lansoprazole—Nasopharyngitis—Dapsone—leprosy	0.000899	0.00625	CcSEcCtD
Lansoprazole—Muscular weakness—Dapsone—leprosy	0.000887	0.00617	CcSEcCtD
Lansoprazole—Influenza—Dapsone—leprosy	0.000869	0.00604	CcSEcCtD
Lansoprazole—Petechiae—Thalidomide—leprosy	0.000862	0.006	CcSEcCtD
Lansoprazole—Endocrine disorder—Thalidomide—leprosy	0.000855	0.00595	CcSEcCtD
Lansoprazole—Pancreatitis—Dapsone—leprosy	0.000852	0.00593	CcSEcCtD
Lansoprazole—Blood disorder—Thalidomide—leprosy	0.000849	0.00591	CcSEcCtD
Lansoprazole—Vasodilation procedure—Thalidomide—leprosy	0.000807	0.00561	CcSEcCtD
Lansoprazole—Vasodilation—Thalidomide—leprosy	0.000807	0.00561	CcSEcCtD
Lansoprazole—Accidental injury—Thalidomide—leprosy	0.000801	0.00557	CcSEcCtD
Lansoprazole—Photosensitivity reaction—Dapsone—leprosy	0.000793	0.00552	CcSEcCtD
Lansoprazole—Musculoskeletal stiffness—Thalidomide—leprosy	0.00079	0.0055	CcSEcCtD
Lansoprazole—Viral infection—Thalidomide—leprosy	0.000785	0.00546	CcSEcCtD
Lansoprazole—Bone disorder—Thalidomide—leprosy	0.000785	0.00546	CcSEcCtD
Lansoprazole—Arthropathy—Thalidomide—leprosy	0.00078	0.00542	CcSEcCtD
Lansoprazole—Hyperbilirubinaemia—Thalidomide—leprosy	0.00078	0.00542	CcSEcCtD
Lansoprazole—Neuropathy peripheral—Dapsone—leprosy	0.000759	0.00528	CcSEcCtD
Lansoprazole—Creatinine increased—Thalidomide—leprosy	0.000745	0.00518	CcSEcCtD
Lansoprazole—Sinusitis—Dapsone—leprosy	0.000727	0.00506	CcSEcCtD
Lansoprazole—Neck pain—Thalidomide—leprosy	0.000718	0.00499	CcSEcCtD
Lansoprazole—Phosphatase alkaline increased—Thalidomide—leprosy	0.000709	0.00493	CcSEcCtD
Lansoprazole—Eructation—Thalidomide—leprosy	0.000697	0.00485	CcSEcCtD
Lansoprazole—Pharyngitis—Dapsone—leprosy	0.00069	0.0048	CcSEcCtD
Lansoprazole—Colitis—Thalidomide—leprosy	0.000681	0.00474	CcSEcCtD
Lansoprazole—Candida infection—Thalidomide—leprosy	0.000677	0.00471	CcSEcCtD
Lansoprazole—Blood urea increased—Thalidomide—leprosy	0.000669	0.00466	CcSEcCtD
Lansoprazole—Aplastic anaemia—Thalidomide—leprosy	0.000666	0.00463	CcSEcCtD
Lansoprazole—Neuropathy—Thalidomide—leprosy	0.000666	0.00463	CcSEcCtD
Lansoprazole—Dry eye—Thalidomide—leprosy	0.000655	0.00456	CcSEcCtD
Lansoprazole—Cramps of lower extremities—Thalidomide—leprosy	0.000651	0.00453	CcSEcCtD
Lansoprazole—Tinnitus—Dapsone—leprosy	0.000648	0.00451	CcSEcCtD
Lansoprazole—Oesophagitis—Thalidomide—leprosy	0.000648	0.00451	CcSEcCtD
Lansoprazole—Rash maculo-papular—Thalidomide—leprosy	0.000644	0.00448	CcSEcCtD
Lansoprazole—Gynaecomastia—Thalidomide—leprosy	0.000634	0.00441	CcSEcCtD
Lansoprazole—Hypertonia—Thalidomide—leprosy	0.000621	0.00432	CcSEcCtD
Lansoprazole—Hyperkinesia—Thalidomide—leprosy	0.000618	0.0043	CcSEcCtD
Lansoprazole—Erythema—Dapsone—leprosy	0.000605	0.00421	CcSEcCtD
Lansoprazole—Lymphadenopathy—Thalidomide—leprosy	0.000603	0.0042	CcSEcCtD
Lansoprazole—Diabetes mellitus—Thalidomide—leprosy	0.000592	0.00412	CcSEcCtD
Lansoprazole—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000592	0.00412	CcSEcCtD
Lansoprazole—Photosensitivity—Thalidomide—leprosy	0.000586	0.00408	CcSEcCtD
Lansoprazole—Gastroenteritis—Thalidomide—leprosy	0.000581	0.00404	CcSEcCtD
Lansoprazole—Vascular purpura—Thalidomide—leprosy	0.000575	0.004	CcSEcCtD
Lansoprazole—Deafness—Thalidomide—leprosy	0.000575	0.004	CcSEcCtD
Lansoprazole—Vision blurred—Dapsone—leprosy	0.000571	0.00397	CcSEcCtD
Lansoprazole—Eye pain—Thalidomide—leprosy	0.00057	0.00397	CcSEcCtD
Lansoprazole—Injury—Thalidomide—leprosy	0.00056	0.0039	CcSEcCtD
Lansoprazole—Renal failure acute—Thalidomide—leprosy	0.000557	0.00388	CcSEcCtD
Lansoprazole—Libido decreased—Thalidomide—leprosy	0.000555	0.00386	CcSEcCtD
Lansoprazole—Increased appetite—Thalidomide—leprosy	0.000548	0.00381	CcSEcCtD
Lansoprazole—Amnesia—Thalidomide—leprosy	0.000548	0.00381	CcSEcCtD
Lansoprazole—Dermatitis exfoliative—Thalidomide—leprosy	0.000545	0.00379	CcSEcCtD
Lansoprazole—Vertigo—Dapsone—leprosy	0.000544	0.00378	CcSEcCtD
Lansoprazole—Purpura—Thalidomide—leprosy	0.000534	0.00371	CcSEcCtD
Lansoprazole—Arthritis—Thalidomide—leprosy	0.00053	0.00368	CcSEcCtD
Lansoprazole—Cough—Dapsone—leprosy	0.000528	0.00368	CcSEcCtD
Lansoprazole—Hypoglycaemia—Thalidomide—leprosy	0.000527	0.00367	CcSEcCtD
Lansoprazole—Cerebrovascular accident—Thalidomide—leprosy	0.000525	0.00365	CcSEcCtD
Lansoprazole—Hyponatraemia—Thalidomide—leprosy	0.000517	0.00359	CcSEcCtD
Lansoprazole—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000515	0.00358	CcSEcCtD
Lansoprazole—Diplopia—Thalidomide—leprosy	0.000515	0.00358	CcSEcCtD
Lansoprazole—Osteoarthritis—Thalidomide—leprosy	0.000515	0.00358	CcSEcCtD
Lansoprazole—Disturbance in sexual arousal—Thalidomide—leprosy	0.000511	0.00355	CcSEcCtD
Lansoprazole—Affect lability—Thalidomide—leprosy	0.000507	0.00352	CcSEcCtD
Lansoprazole—Migraine—Thalidomide—leprosy	0.000507	0.00352	CcSEcCtD
Lansoprazole—Face oedema—Thalidomide—leprosy	0.000497	0.00346	CcSEcCtD
Lansoprazole—Mood swings—Thalidomide—leprosy	0.000488	0.00339	CcSEcCtD
Lansoprazole—Tachycardia—Dapsone—leprosy	0.000482	0.00335	CcSEcCtD
Lansoprazole—Blood creatinine increased—Thalidomide—leprosy	0.000482	0.00335	CcSEcCtD
Lansoprazole—Dehydration—Thalidomide—leprosy	0.000479	0.00333	CcSEcCtD
Lansoprazole—Liver function test abnormal—Thalidomide—leprosy	0.000475	0.00331	CcSEcCtD
Lansoprazole—Dry skin—Thalidomide—leprosy	0.000472	0.00328	CcSEcCtD
Lansoprazole—Hypokalaemia—Thalidomide—leprosy	0.000468	0.00326	CcSEcCtD
Lansoprazole—Breast disorder—Thalidomide—leprosy	0.000465	0.00324	CcSEcCtD
Lansoprazole—Cramp muscle—Thalidomide—leprosy	0.000463	0.00322	CcSEcCtD
Lansoprazole—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000463	0.00322	CcSEcCtD
Lansoprazole—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000463	0.00322	CcSEcCtD
Lansoprazole—Alanine aminotransferase increased—Thalidomide—leprosy	0.000454	0.00316	CcSEcCtD
Lansoprazole—Muscular weakness—Thalidomide—leprosy	0.000454	0.00316	CcSEcCtD
Lansoprazole—Abdominal distension—Thalidomide—leprosy	0.000448	0.00312	CcSEcCtD
Lansoprazole—Insomnia—Dapsone—leprosy	0.000447	0.00311	CcSEcCtD
Lansoprazole—Influenza—Thalidomide—leprosy	0.000445	0.00309	CcSEcCtD
Lansoprazole—Dysphagia—Thalidomide—leprosy	0.000445	0.00309	CcSEcCtD
Lansoprazole—Eosinophilia—Thalidomide—leprosy	0.00044	0.00306	CcSEcCtD
Lansoprazole—Pancreatitis—Thalidomide—leprosy	0.000436	0.00303	CcSEcCtD
Lansoprazole—Angina pectoris—Thalidomide—leprosy	0.000433	0.00301	CcSEcCtD
Lansoprazole—Bronchitis—Thalidomide—leprosy	0.000428	0.00298	CcSEcCtD
Lansoprazole—Pancytopenia—Thalidomide—leprosy	0.000422	0.00294	CcSEcCtD
Lansoprazole—Neutropenia—Thalidomide—leprosy	0.000416	0.00289	CcSEcCtD
Lansoprazole—Upper respiratory tract infection—Thalidomide—leprosy	0.000413	0.00288	CcSEcCtD
Lansoprazole—Pollakiuria—Thalidomide—leprosy	0.000411	0.00286	CcSEcCtD
Lansoprazole—Erectile dysfunction—Thalidomide—leprosy	0.00041	0.00285	CcSEcCtD
Lansoprazole—Photosensitivity reaction—Thalidomide—leprosy	0.000406	0.00282	CcSEcCtD
Lansoprazole—Weight increased—Thalidomide—leprosy	0.000405	0.00282	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Dapsone—leprosy	0.000404	0.00281	CcSEcCtD
Lansoprazole—Hyperglycaemia—Thalidomide—leprosy	0.000401	0.00279	CcSEcCtD
Lansoprazole—Pneumonia—Thalidomide—leprosy	0.000399	0.00278	CcSEcCtD
Lansoprazole—Infestation NOS—Thalidomide—leprosy	0.000397	0.00276	CcSEcCtD
Lansoprazole—Infestation—Thalidomide—leprosy	0.000397	0.00276	CcSEcCtD
Lansoprazole—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000393	0.00274	CcSEcCtD
Lansoprazole—Acute coronary syndrome—Thalidomide—leprosy	0.000391	0.00272	CcSEcCtD
Lansoprazole—Abdominal pain—Dapsone—leprosy	0.000391	0.00272	CcSEcCtD
Lansoprazole—Body temperature increased—Dapsone—leprosy	0.000391	0.00272	CcSEcCtD
Lansoprazole—Renal failure—Thalidomide—leprosy	0.00039	0.00271	CcSEcCtD
Lansoprazole—Neuropathy peripheral—Thalidomide—leprosy	0.000389	0.0027	CcSEcCtD
Lansoprazole—Myocardial infarction—Thalidomide—leprosy	0.000389	0.0027	CcSEcCtD
Lansoprazole—Stomatitis—Thalidomide—leprosy	0.000387	0.00269	CcSEcCtD
Lansoprazole—Conjunctivitis—Thalidomide—leprosy	0.000386	0.00268	CcSEcCtD
Lansoprazole—Sweating—Thalidomide—leprosy	0.00038	0.00265	CcSEcCtD
Lansoprazole—Haematuria—Thalidomide—leprosy	0.000378	0.00263	CcSEcCtD
Lansoprazole—Epistaxis—Thalidomide—leprosy	0.000374	0.0026	CcSEcCtD
Lansoprazole—Sinusitis—Thalidomide—leprosy	0.000372	0.00259	CcSEcCtD
Lansoprazole—Agranulocytosis—Thalidomide—leprosy	0.00037	0.00257	CcSEcCtD
Lansoprazole—Bradycardia—Thalidomide—leprosy	0.000362	0.00252	CcSEcCtD
Lansoprazole—Rhinitis—Thalidomide—leprosy	0.000357	0.00248	CcSEcCtD
Lansoprazole—Hepatitis—Thalidomide—leprosy	0.000356	0.00248	CcSEcCtD
Lansoprazole—Hypoaesthesia—Thalidomide—leprosy	0.000354	0.00246	CcSEcCtD
Lansoprazole—Pharyngitis—Thalidomide—leprosy	0.000353	0.00246	CcSEcCtD
Lansoprazole—Urinary tract disorder—Thalidomide—leprosy	0.000352	0.00245	CcSEcCtD
Lansoprazole—Oedema peripheral—Thalidomide—leprosy	0.000351	0.00244	CcSEcCtD
Lansoprazole—Urethral disorder—Thalidomide—leprosy	0.000349	0.00243	CcSEcCtD
Lansoprazole—Visual impairment—Thalidomide—leprosy	0.000343	0.00239	CcSEcCtD
Lansoprazole—Erythema multiforme—Thalidomide—leprosy	0.000337	0.00234	CcSEcCtD
Lansoprazole—Eye disorder—Thalidomide—leprosy	0.000333	0.00231	CcSEcCtD
Lansoprazole—Tinnitus—Thalidomide—leprosy	0.000332	0.00231	CcSEcCtD
Lansoprazole—Cardiac disorder—Thalidomide—leprosy	0.00033	0.0023	CcSEcCtD
Lansoprazole—Angiopathy—Thalidomide—leprosy	0.000323	0.00225	CcSEcCtD
Lansoprazole—Immune system disorder—Thalidomide—leprosy	0.000322	0.00224	CcSEcCtD
Lansoprazole—Mediastinal disorder—Thalidomide—leprosy	0.000321	0.00223	CcSEcCtD
Lansoprazole—Chills—Thalidomide—leprosy	0.000319	0.00222	CcSEcCtD
Lansoprazole—Arrhythmia—Thalidomide—leprosy	0.000318	0.00221	CcSEcCtD
Lansoprazole—Alopecia—Thalidomide—leprosy	0.000315	0.00219	CcSEcCtD
Lansoprazole—Vomiting—Dapsone—leprosy	0.000314	0.00219	CcSEcCtD
Lansoprazole—Mental disorder—Thalidomide—leprosy	0.000312	0.00217	CcSEcCtD
Lansoprazole—Malnutrition—Thalidomide—leprosy	0.00031	0.00216	CcSEcCtD
Lansoprazole—Headache—Dapsone—leprosy	0.00031	0.00215	CcSEcCtD
Lansoprazole—Flatulence—Thalidomide—leprosy	0.000305	0.00212	CcSEcCtD
Lansoprazole—Tension—Thalidomide—leprosy	0.000304	0.00212	CcSEcCtD
Lansoprazole—Dysgeusia—Thalidomide—leprosy	0.000304	0.00211	CcSEcCtD
Lansoprazole—Nervousness—Thalidomide—leprosy	0.000301	0.00209	CcSEcCtD
Lansoprazole—Back pain—Thalidomide—leprosy	0.0003	0.00209	CcSEcCtD
Lansoprazole—Muscle spasms—Thalidomide—leprosy	0.000298	0.00207	CcSEcCtD
Lansoprazole—Nausea—Dapsone—leprosy	0.000293	0.00204	CcSEcCtD
Lansoprazole—Vision blurred—Thalidomide—leprosy	0.000292	0.00203	CcSEcCtD
Lansoprazole—Tremor—Thalidomide—leprosy	0.00029	0.00202	CcSEcCtD
Lansoprazole—Ill-defined disorder—Thalidomide—leprosy	0.000288	0.002	CcSEcCtD
Lansoprazole—Anaemia—Thalidomide—leprosy	0.000286	0.00199	CcSEcCtD
Lansoprazole—Agitation—Thalidomide—leprosy	0.000285	0.00198	CcSEcCtD
Lansoprazole—Angioedema—Thalidomide—leprosy	0.000283	0.00197	CcSEcCtD
Lansoprazole—Malaise—Thalidomide—leprosy	0.000279	0.00194	CcSEcCtD
Lansoprazole—Vertigo—Thalidomide—leprosy	0.000278	0.00194	CcSEcCtD
Lansoprazole—Syncope—Thalidomide—leprosy	0.000278	0.00193	CcSEcCtD
Lansoprazole—Leukopenia—Thalidomide—leprosy	0.000277	0.00193	CcSEcCtD
Lansoprazole—Palpitations—Thalidomide—leprosy	0.000274	0.00191	CcSEcCtD
Lansoprazole—Loss of consciousness—Thalidomide—leprosy	0.000272	0.0019	CcSEcCtD
Lansoprazole—Cough—Thalidomide—leprosy	0.00027	0.00188	CcSEcCtD
Lansoprazole—Convulsion—Thalidomide—leprosy	0.000269	0.00187	CcSEcCtD
Lansoprazole—Hypertension—Thalidomide—leprosy	0.000268	0.00186	CcSEcCtD
Lansoprazole—Chest pain—Thalidomide—leprosy	0.000264	0.00184	CcSEcCtD
Lansoprazole—Myalgia—Thalidomide—leprosy	0.000264	0.00184	CcSEcCtD
Lansoprazole—Arthralgia—Thalidomide—leprosy	0.000264	0.00184	CcSEcCtD
Lansoprazole—Anxiety—Thalidomide—leprosy	0.000263	0.00183	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000262	0.00182	CcSEcCtD
Lansoprazole—Discomfort—Thalidomide—leprosy	0.000261	0.00181	CcSEcCtD
Lansoprazole—Dry mouth—Thalidomide—leprosy	0.000258	0.0018	CcSEcCtD
Lansoprazole—Confusional state—Thalidomide—leprosy	0.000255	0.00177	CcSEcCtD
Lansoprazole—Oedema—Thalidomide—leprosy	0.000253	0.00176	CcSEcCtD
Lansoprazole—Infection—Thalidomide—leprosy	0.000251	0.00175	CcSEcCtD
Lansoprazole—Shock—Thalidomide—leprosy	0.000249	0.00173	CcSEcCtD
Lansoprazole—Nervous system disorder—Thalidomide—leprosy	0.000248	0.00173	CcSEcCtD
Lansoprazole—Thrombocytopenia—Thalidomide—leprosy	0.000248	0.00172	CcSEcCtD
Lansoprazole—Tachycardia—Thalidomide—leprosy	0.000247	0.00172	CcSEcCtD
Lansoprazole—Skin disorder—Thalidomide—leprosy	0.000246	0.00171	CcSEcCtD
Lansoprazole—Hyperhidrosis—Thalidomide—leprosy	0.000245	0.0017	CcSEcCtD
Lansoprazole—Anorexia—Thalidomide—leprosy	0.000241	0.00168	CcSEcCtD
Lansoprazole—Hypotension—Thalidomide—leprosy	0.000236	0.00164	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Thalidomide—leprosy	0.00023	0.0016	CcSEcCtD
Lansoprazole—Insomnia—Thalidomide—leprosy	0.000229	0.00159	CcSEcCtD
Lansoprazole—Paraesthesia—Thalidomide—leprosy	0.000227	0.00158	CcSEcCtD
Lansoprazole—Dyspnoea—Thalidomide—leprosy	0.000226	0.00157	CcSEcCtD
Lansoprazole—Somnolence—Thalidomide—leprosy	0.000225	0.00156	CcSEcCtD
Lansoprazole—Dyspepsia—Thalidomide—leprosy	0.000223	0.00155	CcSEcCtD
Lansoprazole—Decreased appetite—Thalidomide—leprosy	0.00022	0.00153	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Thalidomide—leprosy	0.000218	0.00152	CcSEcCtD
Lansoprazole—Fatigue—Thalidomide—leprosy	0.000218	0.00152	CcSEcCtD
Lansoprazole—Pain—Thalidomide—leprosy	0.000216	0.0015	CcSEcCtD
Lansoprazole—Constipation—Thalidomide—leprosy	0.000216	0.0015	CcSEcCtD
Lansoprazole—Feeling abnormal—Thalidomide—leprosy	0.000208	0.00145	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Thalidomide—leprosy	0.000207	0.00144	CcSEcCtD
Lansoprazole—Urticaria—Thalidomide—leprosy	0.000201	0.0014	CcSEcCtD
Lansoprazole—Abdominal pain—Thalidomide—leprosy	0.0002	0.00139	CcSEcCtD
Lansoprazole—Body temperature increased—Thalidomide—leprosy	0.0002	0.00139	CcSEcCtD
Lansoprazole—Hypersensitivity—Thalidomide—leprosy	0.000186	0.0013	CcSEcCtD
Lansoprazole—Asthenia—Thalidomide—leprosy	0.000181	0.00126	CcSEcCtD
Lansoprazole—Pruritus—Thalidomide—leprosy	0.000179	0.00124	CcSEcCtD
Lansoprazole—Diarrhoea—Thalidomide—leprosy	0.000173	0.0012	CcSEcCtD
Lansoprazole—Dizziness—Thalidomide—leprosy	0.000167	0.00116	CcSEcCtD
Lansoprazole—Vomiting—Thalidomide—leprosy	0.000161	0.00112	CcSEcCtD
Lansoprazole—Rash—Thalidomide—leprosy	0.000159	0.00111	CcSEcCtD
Lansoprazole—Dermatitis—Thalidomide—leprosy	0.000159	0.00111	CcSEcCtD
Lansoprazole—Headache—Thalidomide—leprosy	0.000158	0.0011	CcSEcCtD
Lansoprazole—Nausea—Thalidomide—leprosy	0.00015	0.00105	CcSEcCtD
